Sona Group Announces New Partnership with Coripharma

Sona Group is pleased to announce the start of its partnership with Coripharma, an international pharmaceutical company headquartered in Iceland.

Within this cooperation, Sona-Pharm in Ukraine will focus on bringing cost-effective targeted oncology solutions to the market, supporting healthcare professionals with reliable and clinically proven therapies that help improve patient access and treatment outcomes.

Coripharma is a global pharmaceutical company specializing in the development and commercialization of high-quality, cost-effective medicines across multiple therapeutic areas, with a strong focus on manufacturing standards and consistent supply.

For Sona Group, this partnership reflects our continued focus on working with strong international partners and expanding access to high-quality, cost-effective treatments in the markets where we operate.

We are grateful to everyone whose work and commitment made this partnership possible.